146 related articles for article (PubMed ID: 14736256)
21. Computational studies and drug design for HIV-1 reverse transcriptase inhibitors of 3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) analogs.
Chen HF; Fan BT; Zhao CY; Xie L; Zhao CH; Zhou T; Lee KH; Allaway G
J Comput Aided Mol Des; 2005 Apr; 19(4):243-58. PubMed ID: 16163451
[TBL] [Abstract][Full Text] [Related]
22. Anti-AIDS agents 86. Synthesis and anti-HIV evaluation of 2',3'-seco-3'-nor DCP and DCK analogues.
Chen Y; Cheng M; Liu FQ; Xia P; Qian K; Yu D; Xia Y; Yang ZY; Chen CH; Morris-Natschke SL; Lee KH
Eur J Med Chem; 2011 Oct; 46(10):4924-36. PubMed ID: 21864952
[TBL] [Abstract][Full Text] [Related]
23. Development and preclinical studies of broad-spectrum anti-HIV agent (3'R,4'R)-3-cyanomethyl-4-methyl-3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone (3-cyanomethyl-4-methyl-DCK).
Xie L; Guo HF; Lu H; Zhuang XM; Zhang AM; Wu G; Ruan JX; Zhou T; Yu D; Qian K; Lee KH; Jiang S
J Med Chem; 2008 Dec; 51(24):7689-96. PubMed ID: 19053755
[TBL] [Abstract][Full Text] [Related]
24. Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents.
Sun IC; Wang HK; Kashiwada Y; Shen JK; Cosentino LM; Chen CH; Yang LM; Lee KH
J Med Chem; 1998 Nov; 41(23):4648-57. PubMed ID: 9804704
[TBL] [Abstract][Full Text] [Related]
25. Highly potent and orally active CCR5 antagonists as anti-HIV-1 agents: synthesis and biological activities of 1-benzazocine derivatives containing a sulfoxide moiety.
Seto M; Aikawa K; Miyamoto N; Aramaki Y; Kanzaki N; Takashima K; Kuze Y; Iizawa Y; Baba M; Shiraishi M
J Med Chem; 2006 Mar; 49(6):2037-48. PubMed ID: 16539392
[TBL] [Abstract][Full Text] [Related]
26. Anti-AIDS agents. Part 61: Anti-HIV activity of new podophyllotoxin derivatives.
Zhu XK; Guan J; Xiao Z; Cosentino LM; Lee KH
Bioorg Med Chem; 2004 Aug; 12(15):4267-73. PubMed ID: 15246103
[TBL] [Abstract][Full Text] [Related]
27. Recent progress in the development of coumarin derivatives as potent anti-HIV agents.
Yu D; Suzuki M; Xie L; Morris-Natschke SL; Lee KH
Med Res Rev; 2003 May; 23(3):322-45. PubMed ID: 12647313
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and anti-human immunodeficiency virus activity of the skeleton isomers of 3',4'-Di-(O)-(-)-camphanoyl-(+)-khellactone.
Nishioka H; Uesugi K; Ueda N; Kondo Y; Tsuji M; Abe H; Harayama T; Hamasaki T; Baba M; Takeuchi Y
Chem Pharm Bull (Tokyo); 2011; 59(8):1075-6. PubMed ID: 21804260
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers.
Turpin JA; Song Y; Inman JK; Huang M; Wallqvist A; Maynard A; Covell DG; Rice WG; Appella E
J Med Chem; 1999 Jan; 42(1):67-86. PubMed ID: 9888834
[TBL] [Abstract][Full Text] [Related]
30. Molecular modeling, design, synthesis, and biological evaluation of novel 3',4'-dicamphanoyl-(+)-cis-khellactone (DCK) analogs as potent anti-HIV agents.
Xie L; Zhao CH; Zhou T; Chen HF; Fan BT; Chen XH; Ma JZ; Li JY; Bao ZY; Lo Z; Yu D; Lee KH
Bioorg Med Chem; 2005 Dec; 13(23):6435-49. PubMed ID: 16061386
[TBL] [Abstract][Full Text] [Related]
31. Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues.
Wang Y; Chen FE; Balzarini J; De Clercq E; Pannecouque C
Chem Biodivers; 2008 Jan; 5(1):168-76. PubMed ID: 18205120
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and anti-HIV properties of novel 6-phenylselenenyl-5-propyluracils.
Miazga A; Felczak K; Siwecka MA; Lipniacki A; Piasek A; Kulikowski T
Acta Biochim Pol; 2007; 54(4):863-8. PubMed ID: 18066398
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and anti-HIV-1 activity of new MKC-442 analogues with an alkynyl-substituted 6-benzyl group.
Aly YL; Pedersen EB; La Colla P; Loddo R
Arch Pharm (Weinheim); 2007 May; 340(5):225-35. PubMed ID: 17464964
[TBL] [Abstract][Full Text] [Related]
34. 1,2,3-Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluation.
Zhan P; Liu X; Fang Z; Pannecouque C; De Clercq E
Bioorg Med Chem; 2009 Sep; 17(17):6374-9. PubMed ID: 19647440
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and HIV inhibition activity of 2',3'-dideoxy-3'-C-hydroxymethyl nucleosides.
Lee-Ruff E; Ostrowski M; Ladha A; Stynes DV; Vernik I; Jiang JL; Wan WQ; Ding SF; Joshi S
J Med Chem; 1996 Dec; 39(26):5276-80. PubMed ID: 8978856
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of novel MKC-442 analogues with potent activities against HIV-1.
El-Brollosy NR; Pedersen EB; Nielsen C
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):236-41. PubMed ID: 12916058
[TBL] [Abstract][Full Text] [Related]
37. Structure-activity relationships in platelet-activating factor. 12. Synthesis and biological evaluation of platelet-activating factor antagonists with anti-HIV-1 activity.
Serradji N; Martin M; Bensaid O; Cisternino S; Rousselle C; Dereuddre-Bosquet N; Huet J; Redeuilh C; Lamouri A; Dong CZ; Clayette P; Scherrmann JM; Dormont D; Heymans F
J Med Chem; 2004 Dec; 47(25):6410-9. PubMed ID: 15566310
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of analogues of flazin, in particular, flazinamide, as promising anti-HIV agents.
Tang JG; Wang YH; Wang RR; Dong ZJ; Yang LM; Zheng YT; Liu JK
Chem Biodivers; 2008 Mar; 5(3):447-60. PubMed ID: 18357553
[TBL] [Abstract][Full Text] [Related]
39. Highly suppressing wild-type HIV-1 and Y181C mutant HIV-1 strains by 10-chloromethyl-11-demethyl-12-oxo-calanolide A with druggable profile.
Xue H; Lu X; Zheng P; Liu L; Han C; Hu J; Liu Z; Ma T; Li Y; Wang L; Chen Z; Liu G
J Med Chem; 2010 Feb; 53(3):1397-401. PubMed ID: 20050672
[TBL] [Abstract][Full Text] [Related]
40. Prodrug design, synthesis and pharmacokinetic evaluation of (3'
Guo H; Zhuang X; Qian K; Sun L; Wang X; Li H; Lee K; Xie L
Acta Pharm Sin B; 2012 Apr; 2(2):213-219. PubMed ID: 23687633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
